In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Yunnan’s Pharmaceutical Firms Eye Medical Cosmetics

This article was originally published in PharmAsia News

Executive Summary

Yunnan province's three leading pharmaceutical companies Yunnan Baiyao, Kunming Shenghuo Pharmaceutical and Kunming Dihon Pharmaceutical are focusing on developing medical cosmetics as a new source of expansion. Shenghuo, aiming to be China's top medical cosmetic brand, will launch four new products this October. Dihon has established a daily chemical branch in Shanghai and launched Dianhong Skin Moisturizer in early 2008. Its chemical product Dianhong Kangwang is projected to hit RMB 200 million ($29.2 million) in revenue this year. Yunnan Baiyao is expected to officially launch its first medical cosmetic product in 2009. Experts observe that local pharmaceutical firms are actively seeking breakthroughs in the tough times. Their inherent strengths in developing medical cosmetic products will provide them leverage for entering the promising industry. (Click here for more - Chinese Language)
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC069516

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel